Nicholas Stollenwerk

Professor Nicholas Stollenwerk is a distinguished faculty member at the UC Davis School of Medicine, specializing in Pulmonary, Critical Care, and Sleep Medicine. His interdisciplinary studies focus on advancing the understanding and treatment of complex pulmonary conditions, with a particular emphasis on bronchoscopic cryoextraction, lung cancer, and interstitial lung disease. His work is pivotal in bridging clinical practice with cutting-edge research, aiming to improve patient outcomes through innovative therapeutic strategies. Professor Stollenwerk's research portfolio is extensive and diverse, reflecting his commitment to addressing some of the most challenging issues in pulmonary medicine. He has made significant contributions to the field through his studies on precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer. His work in this area seeks to tailor treatment plans to individual patient profiles, enhancing the efficacy of interventions and minimizing adverse effects. In addition to his work on lung cancer, Professor Stollenwerk has explored the complexities of drug-induced pulmonary conditions, such as osimertinib-induced eosinophilic pneumonia. His research provides valuable insights into the mechanisms and management of these conditions, offering guidance for clinicians in optimizing patient care. His investigations into the use of bedside ultrasonography in hospitalized patients underscore his dedication to improving diagnostic accuracy and patient management in critical care settings. This research highlights the potential of ultrasonography as a non-invasive, real-time diagnostic tool that can significantly impact clinical decision-making. Furthermore, Professor Stollenwerk has delved into the interstitial lung disease associated with crizotinib in patients with advanced non-small cell lung cancer. His findings contribute to a deeper understanding of the pulmonary complications associated with targeted cancer therapies, informing both clinical practice and future research directions. Lastly, his work on the safety and clinical utility of flexible bronchoscopic cryoextraction in patients with non-neoplasm tracheobronchial obstruction demonstrates his innovative approach to addressing airway obstructions. This research not only enhances the therapeutic options available to clinicians but also improves the quality of life for patients suffering from these debilitating conditions.